Insights into recent findings and clinical application of YAP and TAZ in cancer

JM Franklin, Z Wu, KL Guan - Nature Reviews Cancer, 2023 - nature.com
Decades of research have mapped out the basic mechanics of the Hippo pathway. The
paralogues Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding …

Anti-tumor immune potentiation targets-engineered nanobiotechnologies: design principles and applications

R Jiao, X Lin, Q Zhang, Y Zhang, W Qin, Q Yang… - Progress in Materials …, 2023 - Elsevier
Combined therapeutic strategies hold promises in augmenting antigen release to enhance
anti-tumor immunity, which have garnered attention in numerous scholarly reviews. Beyond …

Nebulized therapy of early orthotopic lung cancer by iron-based nanoparticles: macrophage-regulated ferroptosis of cancer stem cells

Q Feng, W Fang, Y Guo, P Hu, J Shi - Journal of the American …, 2023 - ACS Publications
Cancer stem cells (CSCs) within protumorigenic microlesions are a critical driver in the
initiation and progression of early stage lung cancer, where immune cells provide an …

Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer

Z Li, Z Yang, W Liu, W Zhu, L Yin, Z Han, Y Xian… - Journal of Translational …, 2023 - Springer
Background Epithelial-to-mesenchymal transition (EMT) and cancer stem-like cells (CSLCs)
play crucial role in tumor metastasis and drug-resistance. Disheveled3 (DVL3) is involved in …

The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP

Z Tian, C Xu, W He, Z Lin, W Zhang, K Tao, R Ding… - Cancer Letters, 2023 - Elsevier
Hippo pathway plays a crucial role in the progression of hepatocellular carcinoma (HCC),
and yes-associated protein (YAP) is one of the major factors of the Hippo pathway. However …

Obesity accelerates immune evasion of non-small cell lung carcinoma via TFEB-dependent upregulation of Siglec-15 and glycolytic reprogramming

C Zhang, L Zhou, S Li, J Zhao, X Meng, L Ma, Y Wang… - Cancer Letters, 2022 - Elsevier
Although obesity contributes to tumor incidence and progression in various cancers,
whether obesity impacts the tumor microenvironment (TME) of non-small cell lung cancer …

Glutamine metabolic reprogramming in hepatocellular carcinoma

Y Ye, B Yu, H Wang, F Yi - Frontiers in Molecular Biosciences, 2023 - frontiersin.org
Hepatocellular carcinoma (HCC) is a lethal disease with limited management strategies and
poor prognosis. Metabolism alternations have been frequently unveiled in HCC, including …

Targeting cancer stem cell pathways for lung cancer therapy

M Liu, H Wu, C Xu - Current Opinion in Oncology, 2023 - journals.lww.com
The current review elucidates the characteristics and related regulating pathways of lung
CSCs from essential to preclinical research. We retrospectively introduce an update on the …

HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing

H Wu, Y Liu, Q Liu, Z Li, Y Wan, C Cao, B Wu… - Science …, 2024 - science.org
Hepatocellular carcinoma (HCC) acquires an immunosuppressive microenvironment,
leading to unbeneficial therapeutic outcomes. Hyaluronan-mediated motility receptor …

Deciphering the role of Hippo pathway in lung cancer

S Ghafouri-Fard, Y Poornajaf, BM Hussen… - … -Research and Practice, 2023 - Elsevier
Hippo pathway has been initially recognized as a regulatory mechanism for modulation of
organ size in fruitfly. Subsequently, its involvement in the regulation of homeostasis and …